| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/01/2014 | CN103479721A Proved prescription used for treating influenza |
| 01/01/2014 | CN103479718A Prescription for treating furuncle |
| 01/01/2014 | CN103479713A Proved recipe for treating acute infectious hepatitis |
| 01/01/2014 | CN103479708A Proved recipe used for treating hordeolum |
| 01/01/2014 | CN103479706A Proved prescription used for treating influenza |
| 01/01/2014 | CN103479703A Proved recipe used for treating hordeolum |
| 01/01/2014 | CN103479701A Proved prescription used for treating influenza |
| 01/01/2014 | CN103479700A Medicine for treating beriberi |
| 01/01/2014 | CN103479689A Proved prescription used for treating influenza |
| 01/01/2014 | CN103479685A Foot bath lotion |
| 01/01/2014 | CN103479673A Prescription for treating furuncle |
| 01/01/2014 | CN103479665A Proved recipe used for treating epidemic cerebrospinal meningitis |
| 01/01/2014 | CN103479663A Application of yeast-origin glucan on preparation of drugs for curing hepatitis B virus infection |
| 01/01/2014 | CN103479660A Breast injectant for treating clinic mastitis of cows, and preparation method thereof |
| 01/01/2014 | CN103479659A Application of three kinds of oroxin in preparing drug for resisting staphylococcus aureus infection |
| 01/01/2014 | CN103479657A Hypericin composition for preventing and treating viral myocarditis and application thereof |
| 01/01/2014 | CN103479655A Compound norfloxacin nicotinate soluble powder for animals, and preparation method thereof |
| 01/01/2014 | CN103479654A Boron-containing small molecules as anti-inflammatory agents |
| 01/01/2014 | CN103479646A Application of Kadcoccitones A to in preparation of anti-helicobacter pylori medicament |
| 01/01/2014 | CN103479644A Application of Kadcoccitones A to preparation of anti-tubercle bacillus medicament |
| 01/01/2014 | CN103479641A 阿昔洛韦组合物 Acyclovir composition |
| 01/01/2014 | CN103479637A Application of Lycojaponicumin C in preparation of anti-herpes virus drugs |
| 01/01/2014 | CN103479636A Application of Lycojaponicumin C in preparation of anti-human fungi drugs |
| 01/01/2014 | CN103479631A Application of Lycojaponicumin B in preparation of anti-mycobacterium tuberculosis drugs |
| 01/01/2014 | CN103479629A Application of Lycojaponicumin A in preparation of anti-respiratory syncytial virus drugs |
| 01/01/2014 | CN103479628A Application of Lycojaponicumin A in medicine for inhibiting herpes viruses |
| 01/01/2014 | CN103479619A Application of Sarcaboside A in preparation of medicine for inhibiting respiratory syncytial virus (RSV) |
| 01/01/2014 | CN103479618A Application of Sarcaboside A in medicine for treating dengue virus infection |
| 01/01/2014 | CN103479617A Dehydroandrographolide derivative composition and preparation method as well as application thereof |
| 01/01/2014 | CN103479608A Application of Scopariusins ??in preparation of antihuman fungal medicines |
| 01/01/2014 | CN103479607A Treating or preventing rotavirus infection |
| 01/01/2014 | CN103479599A Valaciclovir hydrochloride capsule preparation and preparation method thereof |
| 01/01/2014 | CN103479590A Preparation method for ZCHH tablets and method for reversing drug tolerance of MRSA (Methicillin-Resistant Staphylococcus Aureus) by using ZCHH and antibiotic together |
| 01/01/2014 | CN103479589A Cefpodoxime proxetil dispersible tablet and preparation method thereof |
| 01/01/2014 | CN103479587A Cefixime dispersible tablets and preparation method thereof |
| 01/01/2014 | CN103479584A Use of solid carrier particles to improve the processability of pharmaceutical agent |
| 01/01/2014 | CN103479583A Potassium sodium dehydroandroan drographolide succinate enteric dry suspension and preparation method thereof |
| 01/01/2014 | CN103479574A Breast injectant used for preventing and treating dry-milk-period dairy cow mastitis and preparation method thereof |
| 01/01/2014 | CN103479569A Ciprofloxacin injection for animals and preparation method thereof |
| 01/01/2014 | CN103479557A Chamomile antibacterial wet tissue and preparation method thereof |
| 01/01/2014 | CN103479536A Clove mouthrinse solution |
| 01/01/2014 | CN103479522A Method for preparing levofloxacin hydrochloride sodium chloride injection |
| 01/01/2014 | CN103478144A Avermectin and griseofulvin composite pesticidal nanoemulsion |
| 01/01/2014 | CN103169891B Novel vitamin C yinqiao tablet |
| 01/01/2014 | CN102793742B Film coating agent for disinfecting dairy cow breasts and preparation method of film coating agent |
| 01/01/2014 | CN102743614B Preparation method of Chinese medicine irrigation solution for treating pudendum-itching type mycotic vaginitis |
| 01/01/2014 | CN102727611B Topical Chinese medicinal composition/preparation with antibacterial, antipruritic and repairing effects, and preparation method thereof |
| 01/01/2014 | CN102716482B Highly pathogenic porcine reproductive and respiratory syndrome live vaccine diluted solution |
| 01/01/2014 | CN102688335B Chinese medicine composition for treating wind-heat type common cold and preparation method of Chinese medicine composition |
| 01/01/2014 | CN102670770B Compound propolis pure Chinese medicinal composition for treating white scour of piglets and preparation method thereof |
| 01/01/2014 | CN102670684B Application of cynanchum atratum total saponin |
| 01/01/2014 | CN102657864B Immune adjuvant of foot-and-mouth disease vaccine and application of immune adjuvant |
| 01/01/2014 | CN102641439B Compound propolis composition for curing chicken infectivity throat bronchitis and preparation method thereof |
| 01/01/2014 | CN102603677B Curcumin-4-mannich base derivative, preparation method and use of curcumin-4-mannich base derivative |
| 01/01/2014 | CN102600382B Traditional Chinese compound preparation for strengthening spleen and soothing liver as well as application thereof |
| 01/01/2014 | CN102579687B Nasal cavity Chinese medicinal washing fluid for rhinitis |
| 01/01/2014 | CN102517354B Preparation method of water-soluble active polysaccharide in boletus edulis, and application thereof |
| 01/01/2014 | CN102488884B Thymopoietin for large dosage injection and application thereof for treating severe hepatitis |
| 01/01/2014 | CN102464729B O-quaternary ammonium salt oligochitosan vanillina Schiff base bacteriostatic agent and preparation method thereof |
| 01/01/2014 | CN102335423B II type adenovirus live vector recombinant vaccine of dog for showing lyssa virus protective antigen by using spike |
| 01/01/2014 | CN102335416B Compound Chinese medicinal composition for treating hog cholera and preparation method thereof |
| 01/01/2014 | CN102335223B Traditional Chinese medicine for treating human papillomavirus infection symptom as well as preparation method and application thereof |
| 01/01/2014 | CN102239179B Integrin peptide, anti-cd 18 beta A antibody for treatment of endotoxin-mediated pro-inflammatory responses and the use |
| 01/01/2014 | CN102164928B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 01/01/2014 | CN101252927B Quinoline derivatives as antibacterial agents |
| 01/01/2014 | CN101001646B Stabilized synthetic immunogen delivery system |
| 12/31/2013 | US8618141 Aryl ureas with angiogenesis inhibiting activity |
| 12/31/2013 | US8618081 Compositions, gels and foams with rheology modulators and uses thereof |
| 12/31/2013 | US8617822 Method of inhibiting binding or activity of MIF by administering a MIF antagonist |
| 12/31/2013 | US8617598 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/31/2013 | US8617587 Tasted masked veterinary solid compositions |
| 12/31/2013 | US8617560 Peptides for vaccination against human CMV |
| 12/31/2013 | CA2705318C Inhibitors of human immunodeficiency virus replication |
| 12/31/2013 | CA2651232C Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350 |
| 12/31/2013 | CA2644661C Prodrugs of benzoquinolizine-2-carboxylic acid |
| 12/31/2013 | CA2609347C Use of chalcones for the treatment of viral disorders |
| 12/31/2013 | CA2596683C Conjugation of streptococcal capsular saccharides |
| 12/31/2013 | CA2533292C Antibiotic product, use and formulation thereof |
| 12/31/2013 | CA2485847C Glucan-based vaccines |
| 12/31/2013 | CA2478371C Compositions and methods for generating an immune response |
| 12/27/2013 | WO2013192589A1 Antibodies targeting hiv escape mutants |
| 12/27/2013 | WO2013192352A1 Antibacterial agents: aryl myxopyronin derivatives |
| 12/27/2013 | WO2013192300A1 Curcumin derivatives for microbial biofilm destruction |
| 12/27/2013 | WO2013192078A1 Synthetic pgpg analogs, methods of preparation and methods of use |
| 12/27/2013 | WO2013191591A1 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae |
| 12/27/2013 | WO2013191565A1 Antimicrobial composition and its method of use |
| 12/27/2013 | WO2013191459A1 Polyvalent pneumococcal polysaccharide-protein conjugate composition |
| 12/27/2013 | WO2013191363A1 Novel bacteriophage, and use for inhibiting proliferation of pathogenic bacteria |
| 12/27/2013 | WO2013190384A1 Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
| 12/27/2013 | WO2013190355A1 Oxathiazine derivatives as antibacterial and anticancer agents |
| 12/27/2013 | WO2013190111A1 Pharmaceutical composition of moxifloxacin hydrochloride and preparation method |
| 12/27/2013 | WO2013190103A1 Sialic acid derivatives |
| 12/27/2013 | WO2013189950A1 Dibenzofuran derivatives with antibacterial and wound-healing activity |
| 12/27/2013 | WO2013189237A1 Andrographolide analogue and application of andrographolide analogue to treatment |
| 12/27/2013 | WO2013189004A1 Peptide nucleic acid of porcine reproductive and respiratory syndrome virus and uses thereof |
| 12/27/2013 | WO2013189003A1 Peptide nucleic acid of subgroup j avian leukosis virus and uses thereof |
| 12/27/2013 | CA2877648A1 Polyvalent pneumococcal polysaccharide-protein conjugate composition |
| 12/27/2013 | CA2877169A1 Pharmaceutical composition of moxifloxacin hydrochloride and preparation method |
| 12/27/2013 | CA2875916A1 Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
| 12/26/2013 | US20130345238 Method of using diketopiperazines and composition containing them |